Dr Philippa C. May

Faculty of Medicine, Department of Immunology and Inflammation

Visiting Researcher

Contact

Location

4N5Commonwealth BuildingHammersmith Campus

Summary

Philippa is a visiting researcher at Imperial College. She completed a PhD in leukaemia genomics in 2018, and finished her first post doc, funded by a Kay Kendall Leukaemia Fund project grant, in 2021.

Philippa's interest is in chromatin modification and non-coding regulatory elements in myeloid leukaemia. She uses various NGS-based methods, such as ChIP-seq, ATAC-seq and chromosome conformation capture-seq (4C). She was given an Early Career Development grant by Leukaemia UK in 2019.

Philippa is a Consultant Clinical Scientist in Genomics and leads the specialist paediatric integrated haematology & malignancy diagnostic service (SIHMDS) at Great Ormond Street Hospital, part of the North Thames Genomic Laboratory Hub. She was previously the lead of Developmental Disorders at Guy's & St Thomas' NHS Foundation Trust and Head of Education and Development for Healthcare Science at the Royal Free London NHS Foundation Trust.

Selected Publications

Journal Articles

Karadimitris A, 2021, Chromatin-based, in cis and in trans regulatory rewiring underpins distinct oncogenic transcriptomes in multiple myeloma, Nature Communications, Vol:12, ISSN:2041-1723, Pages:1-16

Rowan AG, May P, Badhan A, et al.Rowan AG, May P, Badhan A, Herrera C, Watber P, Penn R, Crone MA, Storch M, Garson JA, McClure M, Freemont PS, Madona P, Randell P, Taylor GP close, 2021, Optimized protocol for a quantitative SARS-CoV-2 duplex RT-qPCR assay with internal human sample sufficiency control., Journal of Virological Methods, Vol:294, ISSN:0166-0934, Pages:1-7

Spencer Chapman M, May PC, Olavarria E, et al.Spencer Chapman M, May PC, Olavarria E, Nadal Melsio E close, 2020, Three distinct hematological malignancies from a single germ cell tumor: a case report., Journal of Medical Case Reports, Vol:14, ISSN:1752-1947

Silvestri G, Trotta R, Stramucci L, et al.Silvestri G, Trotta R, Stramucci L, Ellis JJ, Harb JG, Neviani P, Wang S, Eisfeld A-K, Walker CJ, Zhang B, Srutova K, Gambacorti-Passerini C, Pineda G, Jamieson CHM, Stagno F, Vigneri P, Nteliopoulos G, May PC, Reid AG, Garzon R, Roy D-C, Moutuou MM, Guimond M, Hokland P, Deininger MW, Fitzgerald G, Harman C, Dazzi F, Milojkovic D, Apperley JF, Marcucci G, Qi J, Polakova KM, Zou Y, Fan X, Baer MR, Calabretta B, Perrotti D close, 2020, Persistence of Drug-Resistant Leukemic Stem Cells and Impaired NK Cell Immunity in CML Patients Depend on MIR300 Antiproliferative and PP2A-Activating Functions, Blood Cancer Discovery, Vol:1, ISSN:2643-3230, Pages:48-67

Innes A, Wooley P, Szydlo R, et al.Innes A, Wooley P, Szydlo R, Lozano S, Fernando F, Bansal D, Palanicawandar R, Milojkovic D, May P, Nadal-Melsio E, Yebra-Fernandez E, Olavarria E, Apperley J, Pavlu J close, 2019, Complete remission with incomplete count recovery (CRi) prior to allogeneic HCT for acute myeloid leukaemia is associated with a high non-relapse mortality., Leukemia, Vol:34, ISSN:1476-5551, Pages:667-670

Boulianne B, Robinson ME, May PC, et al.Boulianne B, Robinson ME, May PC, Castellano L, Blighe K, Thomas J, Reid A, Muschen M, Apperley JF, Stebbing J, Feldhahn N close, 2017, Lineage-specific genes are prominent DNA damage hotspots during leukemic transformation of B-cell precursors, Cell Reports, Vol:18, ISSN:2211-1247, Pages:1687-1698

More Publications